EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Phibro Animal Health's Enterprise Value is €1,087.3 Mil.
Phibro Animal Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was €37.2 Mil. Therefore, Phibro Animal Health's EV-to-FCF for today is 29.20.
The historical rank and industry rank for Phibro Animal Health's EV-to-FCF or its related term are showing as below:
FRA:PB8'
s EV-to-FCF Range Over the Past 10 Years
Min: -562.12 Med: 38.96 Max: 1618.43
Current: 29.14
During the past 13 years, the highest EV-to-FCF of Phibro Animal Health was 1618.43. The lowest was -562.12. And the median was 38.96.
FRA:PB8's EV-to-FCF is ranked worse than 55.62% of 525
companies
in the Drug Manufacturers industry
Industry Median: 24.52
vs FRA:PB8: 29.14
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for Phibro Animal Health's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Phibro Animal Health's EV-to-FCF
For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phibro Animal Health's EV-to-FCF Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Phibro Animal Health's EV-to-FCF falls into.
Phibro Animal Health's current Enterprise Value is €1,087.3 Mil.
Phibro Animal Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €37.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phibro Animal Health (FRA:PB8) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Phibro Animal Health's PE Ratio for today is calculated as:
Phibro Animal Health's share price for today is €16.90.
Phibro Animal Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.302.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Phibro Animal Health EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Phibro Animal Health's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Phibro Animal Health (FRA:PB8) Business Description
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:PB8 has been successfully added to your 